Overview
Heart-hand syndrome (Orphanet code 228184) is a group of rare genetic disorders characterized by the co-occurrence of congenital heart defects and limb (particularly hand and forearm) abnormalities. This designation encompasses several distinct clinical entities in which cardiac and upper limb malformations present together, reflecting shared developmental pathways during embryogenesis. The most well-known subtypes include Holt-Oram syndrome (heart-hand syndrome type I), which is caused by mutations in the TBX5 gene, as well as other rarer forms. The cardiac manifestations typically include atrial and ventricular septal defects, conduction abnormalities (such as atrioventricular block), and other structural heart malformations. Upper limb anomalies range from subtle findings such as triphalangeal or absent thumbs to more severe defects including radial ray abnormalities, hypoplastic or absent radius, and phocomelia. The severity of both cardiac and limb involvement is highly variable, even within the same family. Diagnosis is typically made in the neonatal period or during childhood based on clinical findings, echocardiography, skeletal radiographs, and genetic testing. Management is multidisciplinary and depends on the specific manifestations present. Cardiac defects may require surgical repair or medical management of arrhythmias, while limb abnormalities may benefit from orthopedic interventions, occupational therapy, or reconstructive surgery. Genetic counseling is recommended for affected individuals and their families. There is currently no cure, and treatment remains supportive and symptom-directed.
Also known as:
Variable
Can be inherited in different ways depending on the underlying gene
Neonatal
Begins at or shortly after birth (first 4 weeks)
FDA & Trial Timeline
1 eventAcibadem University — NA
Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
Treatments
No FDA-approved treatments are currently listed for Heart-hand syndrome.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Heart-hand syndrome at this time.
New trials open frequently. Follow this disease to get notified.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Heart-hand syndrome.
Community
No community posts yet. Be the first to share your experience with Heart-hand syndrome.
Start the conversation →Latest news about Heart-hand syndrome
Disease timeline:
New recruiting trial: Effect of Fan Application in Preventing Ticagrelor-Associated Dyspnea
A new clinical trial is recruiting patients for Heart-hand syndrome
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Heart-hand syndrome
What is Heart-hand syndrome?
Heart-hand syndrome (Orphanet code 228184) is a group of rare genetic disorders characterized by the co-occurrence of congenital heart defects and limb (particularly hand and forearm) abnormalities. This designation encompasses several distinct clinical entities in which cardiac and upper limb malformations present together, reflecting shared developmental pathways during embryogenesis. The most well-known subtypes include Holt-Oram syndrome (heart-hand syndrome type I), which is caused by mutations in the TBX5 gene, as well as other rarer forms. The cardiac manifestations typically include at
At what age does Heart-hand syndrome typically begin?
Typical onset of Heart-hand syndrome is neonatal. Age of onset can vary across affected individuals.
Which specialists treat Heart-hand syndrome?
1 specialists and care centers treating Heart-hand syndrome are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.